Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals

NAUnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Analgesic Response
Interventions
DRUG

morphine sulfate

Participants will receive randomly assigned order of study drug (opioid) and then have 7 days of testing with test days at least 3 days apart. Pain testing will utilize cold pressor test, in which the participant submerges his arm and hand in a bath of ice cold water to determine pain threshold and tolerance.

DRUG

hydrocodone

Participants will receive randomly assigned order of study drug (opioid) and then have 7 days of testing with test days at least 3 days apart. Pain testing will utilize cold pressor test, in which the participant submerges his arm and hand in a bath of ice cold water to determine pain threshold and tolerance.

DRUG

hydromorphone HCI

Participants will receive randomly assigned order of study drug (opioid) and then have 7 days of testing with test days at least 3 days apart. Pain testing will utilize cold pressor test, in which the participant submerges his arm and hand in a bath of ice cold water to determine pain threshold and tolerance.

DRUG

oxycodone

Participants will receive randomly assigned order of study drug (opioid) and then have 7 days of testing with test days at least 3 days apart. Pain testing will utilize cold pressor test, in which the participant submerges his arm and hand in a bath of ice cold water to determine pain threshold and tolerance.

DRUG

buprenorphine

Participants will receive randomly assigned order of study drug (opioid) and then have 7 days of testing with test days at least 3 days apart. Pain testing will utilize cold pressor test, in which the participant submerges his arm and hand in a bath of ice cold water to determine pain threshold and tolerance.

DRUG

oral tablet placebo

Participants will receive randomly assigned order of study drug (opioid) and then have 7 days of testing with test days at least 3 days apart. Pain testing will utilize cold pressor test, in which the participant submerges his arm and hand in a bath of ice cold water to determine pain threshold and tolerance.

DRUG

sublingual tablet placebo

Participants will receive randomly assigned order of study drug (opioid) and then have 7 days of testing with test days at least 3 days apart. Pain testing will utilize cold pressor test, in which the participant submerges his arm and hand in a bath of ice cold water to determine pain threshold and tolerance.

Trial Locations (1)

90025

RECRUITING

UCLA Integrated Substance Abuse Programs Outpatient Clinical Research Center, Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Indivior Inc.

INDUSTRY

lead

University of California, Los Angeles

OTHER

NCT02136784 - Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals | Biotech Hunter | Biotech Hunter